← Leaderboards
Anne Klibanski
Massachusetts Institute Of Technology
$29,924,622
Attributed
$39,497,481
Total exposure
69
Grants
48
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–18$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$39,497,481 · 69
By mechanism
R01$22,728,437 · 6
R24$11,898,902 · 2
M01$4,260,001 · 59
R56$610,141 · 2
Top collaborators
- Mark C Horowitz9 shared
- Ormond A Macdougald9 shared
- Clifford J Rosen9 shared
- David B Herzog3 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Jane-Jane Chen$5,525,108
- Chi-Sang Poon$10,383,721
Others in their field
Top investigators on “Anorexia Nervosa”
- James D Lock · Stanford University$20,294,888
- Walter H Kaye · University Of Pittsburgh At Pittsburgh$16,361,706
- Cynthia M Bulik · Virginia Commonwealth University$13,871,828
- B. Timothy Walsh · New York State Psychiatric Institute$8,288,260
- Evelyn Attia · Columbia University Health Sciences$7,808,886
- Joanna E Steinglass · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc$7,071,596
Research focus
Anorexia NervosaClinical ResearchBone DensityHuman SubjectGrantFemaleWomanHormone TherapyResearch PersonnelResourcesSourceFundingPhysiologicalComputer Retrieval Of Information On Scientific Projects DatabaseBody CompositionInstitutionUnited States National Institutes Of HealthHuman Therapy EvaluationInsulinlike Growth FactorTestosteroneSomatotropinHormonesBone MetabolismEstrogens
Grant awards (146)
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism, and Energy Balance$1,587,121
R24 · FY2018 · DK
The Role of lncRNA MEG3 in Clinically Non-functioning Pituitary Adenomas$377,034
R01 · FY2018 · CA · contact PI
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism, and Energy Balance$1,598,658
R24 · FY2017 · DK
The Role of lncRNA MEG3 in Clinically Non-functioning Pituitary Adenomas$377,034
R01 · FY2017 · CA · contact PI
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism, and Energy Balance$1,613,109
R24 · FY2016 · DK
The Role of lncRNA MEG3 in Clinically Non-functioning Pituitary Adenomas$377,034
R01 · FY2016 · CA · contact PI
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism, and Energy Balance$1,675,425
R24 · FY2015 · DK
IGF-I and Bone Loss in Women with Anorexia Nervosa$652,177
R01 · FY2015 · DK · contact PI
Effects of Anorexia Nervosa on Peak Bone Mass$632,415
R01 · FY2015 · DK · contact PI
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance$1,241,836
R24 · FY2014 · DK
Effects of Anorexia Nervosa on Peak Bone Mass$656,736
R01 · FY2014 · DK · contact PI
IGF-I and Bone Loss in Women with Anorexia Nervosa$652,177
R01 · FY2014 · DK · contact PI
Hormonal Factors in the Treatment of Anorexia Nervosa$419,090
R01 · FY2014 · MH · contact PI
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance$1,184,108
R24 · FY2013 · DK
Effects of Anorexia Nervosa on Peak Bone Mass$647,561
R01 · FY2013 · DK · contact PI
IGF-I and Bone Loss in Women with Anorexia Nervosa$629,351
R01 · FY2013 · DK · contact PI
Hormonal Factors in the Treatment of Anorexia Nervosa$404,167
R01 · FY2013 · MH · contact PI
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance$1,227,055
R24 · FY2012 · DK
Effects of Anorexia Nervosa on Peak Bone Mass$703,692
R01 · FY2012 · DK · contact PI
IGF-I and Bone Loss in Women with Anorexia Nervosa$652,179
R01 · FY2012 · DK · contact PI
Hormonal Factors in the Treatment of Anorexia Nervosa$423,102
R01 · FY2012 · MH · contact PI
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance$1,270,505
R24 · FY2011 · DK
Effects of Anorexia Nervosa on Peak Bone Mass$797,518
R01 · FY2011 · DK · contact PI
IGF-I and Bone Loss in Women with Anorexia Nervosa$741,954
R01 · FY2011 · DK · contact PI
Hormonal Factors in the Treatment of Anorexia Nervosa$425,285
R01 · FY2011 · MH · contact PI
Interdisciplinary study of marrow adiposity, mineral metabolism,and energy balanc$501,085
R24 · FY2010 · DK
Hormonal Factors in the Treatment of Anorexia Nervosa$448,978
R01 · FY2010 · MH · contact PI
Hormone Regulation and Pathogenesis of Pituitary Tumors$381,427
R01 · FY2010 · DK · contact PI
IGF-1 and Bone Loss in Women with Anorexia Nervosa$92,098
R56 · FY2010 · DK · contact PI
Hormone Regulation and Pathogenesis of Pituitary Tumors$381,078
R01 · FY2009 · DK · contact PI
IGF-1 and Bone Loss in Women with Anorexia Nervosa$182,882
R56 · FY2009 · DK · contact PI
Hormone Regulation and Pathogenesis of Pituitary Tumors$335,161
R56 · FY2008 · DK · contact PI
HORMONE DYNAMICS AND BONE MINERAL DENSITY IN ANOREXIA NERVOSA VS HA (SEE 0630)$38,853
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: EFFECTS OF ANOREXIA NERVOSA ON PEAK BONE MASS$31,244
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: THE EFFECTS OF TESTOSTERONE AND ACTONEL ON BONE DENSITY IN ANORE$22,016
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: GH ADMINISTRATION ON CARDIOVASCULAR RISK IN SUBJECTS W/GROWTH HO$15,703
M01 · FY2008 · RR · contact PI
OSTEOPENIA IN DISORDERED EATING AND ATHLETE$13,275
M01 · FY2008 · RR · contact PI
THE EFFECT OF ANOREXIA NERVOSA ON PEAK BONE MASS$8,256
M01 · FY2008 · RR · contact PI
OSTEOPENIA IN ANOREXIA NERVOSA$5,018
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: EFFECTS OF SUPRAPHYSIOLOGICAL RHGH ON BONE METABOLISM IN ANOREXI$3,724
M01 · FY2008 · RR · contact PI
HORMONE DYNAMICS AND BONE MINERAL DENSITY IN ANOREXIA NERVOSA VS HYPOTHALAMIC$2,267
M01 · FY2008 · RR · contact PI
EFFECTS OF PHYSIOLOGIC GROWTH HORMONE ADMINISTRATION ON CARDIOVASCULAR RISK IN$971
M01 · FY2008 · RR · contact PI
EFFECTS OF SUPRAPHYSIOLOGICAL RHGH ON BONE METABOLISM IN ANOREXIA NERVOSA$647
M01 · FY2008 · RR · contact PI
NEUROENDOCRINE FACTORS IN ADOLESCENT OBESITY$486
M01 · FY2008 · RR · contact PI
PHYSIOLOGIC GH ADMIN ON CARDIOVASCULAR RISK MARKERS IN WOMEN WITH GH DEFICIENCY$312
M01 · FY2008 · RR · contact PI
GENDER-SPECIFIC EFFECTS OF PHYSIOLOGIC GH ADMINISTRATION ON CARDIOVASCULAR RISK$162
M01 · FY2008 · RR · contact PI
Effects of Anorexia Nervosa on Peak Bone Mass$714,168
R01 · FY2007 · DK · contact PI
IGF-1 and Bone Loss in Women Anorexia Nervosa$565,308
R01 · FY2007 · DK · contact PI
EFFECTS OF ANOREXIA NERVOSA ON PEAK BONE MASS$102,874
M01 · FY2007 · RR · contact PI
HORMONE DYNAMICS AND BONE MINERAL DENSITY IN ANOREXIA NERVOSA VS HA (SEE 0630)$71,047
M01 · FY2007 · RR · contact PI
THE EFFECTS OF TESTOSTERONE AND ACTONEL ON BONE DENSITY IN ANOREXIA NERVOSA$64,939
M01 · FY2007 · RR · contact PI
NEUROENDOCRINE FACTORS IN ADOLESCENT OBESITY$49,830
M01 · FY2007 · RR · contact PI
OSTEOPENIA IN ANOREXIA NERVOSA$31,827
M01 · FY2007 · RR · contact PI
OSTEOPENIA IN DISORDERED EATING AND ATHLETE$30,541
M01 · FY2007 · RR · contact PI
THE EFFECT OF ANOREXIA NERVOSA ON PEAK BONE MASS$28,612
M01 · FY2007 · RR · contact PI
PHYSIOLOGIC GH ADMIN ON CARDIOVASCULAR RISK MARKERS IN WOMEN WITH GH DEFICIENCY$16,717
M01 · FY2007 · RR · contact PI
GH ADMINISTRATION ON CARDIOVASCULAR RISK IN SUBJECTS W/GROWTH HORMONE DEFICENCY$16,717
M01 · FY2007 · RR · contact PI
EFFECTS OF PHYSIOLOGIC GROWTH HORMONE ADMINISTRATION ON CARDIOVASCULAR RISK IN$10,930
M01 · FY2007 · RR · contact PI
HORMONE DYNAMICS AND BONE MINERAL DENSITY IN ANOREXIA NERVOSA VS HYPOTHALAMIC$9,966
M01 · FY2007 · RR · contact PI
EFFECTS OF SUPRAPHYSIOLOGICAL RHGH ON BONE METABOLISM IN ANOREXIA NERVOSA$8,680
M01 · FY2007 · RR · contact PI
GENDER-SPECIFIC EFFECTS OF PHYSIOLOGIC GH ADMINISTRATION ON CARDIOVASCULAR RISK$7,072
M01 · FY2007 · RR · contact PI
NEUROENDOCRINE MODULATION OF METABOLIC EFFECTSJ IN OVERWEIGHT ADOLESCENTS$5,143
M01 · FY2007 · RR · contact PI
EFFECTS OF SUPRAPHYSIOLOGICAL RHGH ON BONE METABOLISM IN ANOREXIA NERVOSA$1,608
M01 · FY2007 · RR · contact PI
Effects of Anorexia Nervosa on Peak Bone Mass$735,499
R01 · FY2006 · DK · contact PI
IGF-1 and Bone Loss in Women Anorexia Nervosa$579,177
R01 · FY2006 · DK · contact PI
Hormone Regulation and Pathogenesis of Pituitary Tumors$441,804
R01 · FY2006 · DK · contact PI
EFFECTS OF ANOREXIA NERVOSA ON PEAK BONE MASS$146,618
M01 · FY2006 · RR · contact PI
THE EFFECTS OF TESTOSTERONE AND ACTONEL ON BONE DENSITY IN ANOREXIA NERVOSA$79,265
M01 · FY2006 · RR · contact PI
PHYSIOLOGIC GH ADMIN ON CARDIOVASCULAR RISK MARKERS IN WOMEN WITH GH DEFICIENCY$52,980
M01 · FY2006 · RR · contact PI
OSTEOPENIA IN ANOREXIA NERVOSA$43,124
M01 · FY2006 · RR · contact PI
NEUROENDOCRINE FACTORS IN ADOLESCENT OBESITY$40,249
M01 · FY2006 · RR · contact PI
OSTEOPENIA IN ANOREXIA NERVOSA$38,605
M01 · FY2006 · RR · contact PI
THE EFFECT OF ANOREXIA NERVOSA ON PEAK BONE MASS$37,785
M01 · FY2006 · RR · contact PI
EFFECTS OF PHYSIOLOGIC GROWTH HORMONE ADMINISTRATION ON CARDIOVASCULAR RISK IN$25,464
M01 · FY2006 · RR · contact PI
GENDER-SPECIFIC EFFECTS OF PHYSIOLOGIC GH ADMINISTRATION ON CARDIOVASCULAR RISK$18,482
M01 · FY2006 · RR · contact PI
NEUROENDOCRINE MODULATION OF METABOLIC EFFECTSJ IN OVERWEIGHT ADOLESCENTS$4,928
M01 · FY2006 · RR · contact PI
GH ADMINISTRATION ON CARDIOVASCULAR RISK IN SUBJECTS W/GROWTH HORMONE DEFICENCY$4,107
M01 · FY2006 · RR · contact PI
ANDROGEN REPLACEMENT THERAPY IN WOMEN WITH HYPOPITUITARISM$3,696
M01 · FY2006 · RR · contact PI
Effects of Anorexia Nervosa on Peak Bone Mass$761,549
R01 · FY2005 · DK
IGF-1 and Bone Loss in Women Anorexia Nervosa$574,671
R01 · FY2005 · DK
Hormone Regulation and Pathogenesis of Pituitary Tumors$354,436
R01 · FY2005 · DK
EFFECTS OF ANOREXIA NERVOSA ON PEAK BONE MASS$135,313
M01 · FY2005 · RR
PHYSIOLOGIC GH ADMIN ON CARDIOVASCULAR RISK MARKERS IN WOMEN WITH GH DEFICIENCY$70,764
M01 · FY2005 · RR
Hormone Regulation and Pathogenesis of Pituitary Tumors$65,333
R01 · FY2005 · DK
OSTEOPENIA IN ANOREXIA NERVOSA$51,161
M01 · FY2005 · RR
ANDROGEN REPLACEMENT THERAPY IN WOMEN WITH HYPOPITUITARISM$49,248
M01 · FY2005 · RR
OSTEOPENIA IN ANOREXIA NERVOSA$38,729
M01 · FY2005 · RR
THE EFFECTS OF TESTOSTERONE AND ACTONEL ON BONE DENSITY IN ANOREXIA NERVOSA$35,383
M01 · FY2005 · RR
THE EFFECT OF ANOREXIA NERVOSA ON PEAK BONE MASS$26,297
M01 · FY2005 · RR
GENDER-SPECIFIC EFFECTS OF PHYSIOLOGIC GH ADMINISTRATION ON CARDIOVASCULAR RISK$17,691
M01 · FY2005 · RR
THE EFFECTS OF RHIGF-I AND ACTONEL ON BONE DENSITY IN ANOREXIA NERVOSA$10,998
M01 · FY2005 · RR
GROWTH HORMONE AND GLUCOCORTICOID MYOPATHY$6,215
M01 · FY2005 · RR
GROWTH HORMONE AND GLUCOCORTICOID MYOPATHY$2,391
M01 · FY2005 · RR
EFFECTS OF PHYSIOLOGIC GROWTH HORMONE ADMINISTRATION ON CARDIOVASCULAR RISK IN$478
M01 · FY2005 · RR
Effects of Anorexia Nervosa on Peak Bone Mass$753,199
R01 · FY2004 · DK
IGF-1 and Bone Loss in Women Anorexia Nervosa$572,749
R01 · FY2004 · DK
TESTOSTERONE AND EXERCISE IN MEN AND WOMEN WITH AIDS$551,250
R01 · FY2004 · DK
Hormone Regulation and Pathogenesis of Pituitary Tumors$354,436
R01 · FY2004 · DK
ANDROGEN REPLACEMENT THERAPY IN WOMEN WITH HYPOPITUITARISM$56,966
M01 · FY2004 · RR
THE EFFECTS OF RHIGF-I AND ACTONEL ON BONE DENSITY IN ANOREXIA NERVOSA$54,201
M01 · FY2004 · RR
GROWTH HORMONE AND GLUCOCORTICOID MYOPATHY$41,480
M01 · FY2004 · RR
OSTEOPENIA IN ANOREXIA NERVOSA$33,737
M01 · FY2004 · RR
EFFECTS OF ANOREXIA NERVOSA ON PEAK BONE MASS$28,207
M01 · FY2004 · RR
PHYSIOLOGIC GH ADMIN. ON CARDIOVASCULAR RISK MARKERS IN WOMEN WITH GH DEFICIENCY$27,654
M01 · FY2004 · RR
OSTEOPENIA IN ANOREXIA NERVOSA$27,100
M01 · FY2004 · RR
GROWTH HORMONE AND GLUCOCORTICOID MYOPATHY$13,826
M01 · FY2004 · RR
THE PHYSIOLOGY OF GROWTH HORMONE RESISTANCE IN ADOLESCENTS WITH ANOREXIA NERVOSA$9,955
M01 · FY2004 · RR
THE PHYSIOLOGY OF GROWTH HORMONE RESISTANCE IN ADOLESCENTS W/ ANOREXIA NERVOSA$9,955
M01 · FY2004 · RR
GENDER-SPECIFIC EFFECTS OF PHYSIOLOGIC GH ADMINISTRATION ON CARDIOVASCULAR RISK$4,978
M01 · FY2004 · RR
THE EFFECT OF ANOREXIA NERVOSA ON PEAK BONE MASS$3,318
M01 · FY2004 · RR
Effects of Anorexia Nervosa on Peak Bone Mass$780,515
R01 · FY2003 · DK
TESTOSTERONE AND EXERCISE IN MEN AND WOMEN WITH AIDS$545,691
R01 · FY2003 · DK
IGF-1 and Bone Loss in Women Anorexia Nervosa$491,398
R01 · FY2003 · DK
Hormone Regulation and Pathogenesis of Pituitary Tumors$332,887
R01 · FY2003 · DK
TESTOSTERONE AND EXERCISE IN MEN AND WOMEN WITH AIDS$540,862
R01 · FY2002 · DK
Androgen deficiency and Osteopenia in Anorexia Nervosa$200,768
M01 · FY2002 · RR
Androgen deficiency and Osteopenia in Anorexia Nervosa$200,768
M01 · FY2002 · RR
Consequences--Functional Hypogonadism/Hyperprolactinemia$200,768
M01 · FY2002 · RR
Consequences--Functional Hypogonadism/Hyperprolactinemia$200,768
M01 · FY2002 · RR
EFFECTS OF ANOREXIA NERVOSA ON BONE METABOLISM IN FEMALE ADOLESCENTS$200,768
M01 · FY2002 · RR
EFFECTS OF ANOREXIA NERVOSA ON BONE METABOLISM IN FEMALE ADOLESCENTS$200,768
M01 · FY2002 · RR
RHIGF 1 &Estrogen on Bone Density in Anorexa Nervosa$200,768
M01 · FY2002 · RR
RHIGF 1 &Estrogen on Bone Density in Anorexa Nervosa$200,768
M01 · FY2002 · RR
HORMONE REGULATION AND PATHOGENESIS OF PITUITARY TUMORS$89,616
R01 · FY2002 · DK
TESTOSTERONE AND EXERCISE IN MEN AND WOMEN WITH AIDS$519,717
R01 · FY2001 · DK
IGF-I AND BONE LOSS IN WOMEN WITH ANOREXIA NERVOSA$423,076
R01 · FY2001 · DK
Consequences--Functional Hypogonadism/Hyperprolactinemia$200,768
M01 · FY2001 · RR
RHIGF 1 &Estrogen on Bone Density in Anorexa Nervosa$200,768
M01 · FY2001 · RR
EFFECTS OF ANOREXIA NERVOSA ON BONE METABOLISM IN FEMALE ADOLESCENTS$200,768
M01 · FY2001 · RR
Androgen deficiency and Osteopenia in Anorexia Nervosa$200,768
M01 · FY2001 · RR
RHIGF 1 &Estrogen on Bone Density in Anorexa Nervosa$0
M01 · FY2001 · RR
Androgen deficiency and Osteopenia in Anorexia Nervosa$0
M01 · FY2001 · RR
Consequences--Functional Hypogonadism/Hyperprolactinemia$0
M01 · FY2001 · RR
EFFECTS OF ANOREXIA NERVOSA ON BONE METABOLISM IN FEMALE ADOLESCENTS$0
M01 · FY2001 · RR
TESTOSTERONE AND EXERCISE IN MEN AND WOMEN WITH AIDS$515,264
R01 · FY2000 · DK
IGF-I AND BONE LOSS IN WOMEN WITH ANOREXIA NERVOSA$412,722
R01 · FY2000 · DK
HORMONE REGULATION AND PATHOGENESIS OF PITUITARY TUMORS$273,121
R01 · FY2000 · DK
EFFECTS OF ANOREXIA NERVOSA ON BONE METABOLISM IN FEMALE ADOLESCENTS$0
M01 · FY2000 · RR
RHIGF 1 &Estrogen on Bone Density in Anorexa Nervosa$0
M01 · FY2000 · RR
Androgen deficiency and Osteopenia in Anorexia Nervosa$0
M01 · FY2000 · RR
AIDS wasting in women: Anabolic effects of testosterone physiology study$0
M01 · FY2000 · RR
Androgen deficiency and Osteopenia in Anorexia Nervosa$0
M01 · FY2000 · RR
Consequences--Functional Hypogonadism/Hyperprolactinemia$0
M01 · FY2000 · RR
Consequences--Functional Hypogonadism/Hyperprolactinemia$0
M01 · FY2000 · RR
EFFECTS OF ANOREXIA NERVOSA ON BONE METABOLISM IN FEMALE ADOLESCENTS$0
M01 · FY2000 · RR
RHIGF 1 &Estrogen on Bone Density in Anorexa Nervosa$0
M01 · FY2000 · RR